[In vitro antituberculous activity of lividomycin].
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000494:pharmacology*; D002207:Capreomycin / Q000494:pharmacology; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D007612:Kanamycin / Q000494:pharmacology; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D014756:Viomycin / Q000494:pharmacology
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D002207:Capreomycin; D007612:Kanamycin; D004096:Dihydrostreptomycin Sulfate; D014756:Viomycin